A follow-up study to evaluate the risk of later development of type 1 diabetes in the gestational diabetes mellitus patients with presence of GAD antibody in Japan

A follow-up study to evaluate the risk of later development of type 1 diabetes in the gestational diabetes mellitus patients with presence of GAD antibody in Japan - Positive GAD-GDM in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029438

Enrollment

Registered

2018-01-01

Start date

2017-08-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: gestational diabetes mellitus patients with presence of GAD antibodies in Japan

Exclusion criteria

Exclusion criteria: Overt DM in pregnancy type 1 diabetes in pregnancy

Design outcomes

Primary

Measure	Time frame
development of type 1 diabetes	—

Secondary

Measure	Time frame
Antibody titer of GAD Glucose tolerance Ability of insulin secretion Insulin sensitivity HbA1c	—

Countries

Japan

Contacts

Public ContactTakeshi Nishikawa

National Hospital Organization, Kumamoto Medial Center Department of Diabetes and Endocrinology

takeshi129@gmail.com096-353-6501

Outcome results